Literature DB >> 10364563

GC factor 2 represses platelet-derived growth factor A-chain gene transcription and is itself induced by arterial injury.

L M Khachigian1, F S Santiago, L A Rafty, O L Chan, G J Delbridge, A Bobik, T Collins, A C Johnson.   

Abstract

Platelet-derived growth factor (PDGF) is a mitogen and chemoattractant for a wide variety of cell types. The genes encoding PDGF A chain (PDGF-A) and PDGF B chain (PDGF-B) reside on separate chromosomes and are independently regulated at the level of transcription. Regulatory events underlying inducible PDGF-A expression have been the focus of much investigation. However, mechanisms that inhibit transcription of this gene are not well understood. In this study, we report the capacity of a newly cloned DNA binding factor, GC factor 2 (GCF2), to repress expression driven by the human PDGF-A promoter. 5' Deletion and transient cotransfection analysis in vascular endothelial cells revealed that GCF2 repression is mediated by a nucleotide region located in the proximal region of the PDGF-A promoter. Electrophoretic mobility shift assays demonstrate that GCF2 binds to this region in a specific and dose-dependent manner. Interestingly, the site bound by GCF2 overlaps those for specificity protein-1 (Sp1) and early growth response factor-1 (Egr-1), zinc finger transcription factors that direct basal and inducible expression of the PDGF-A gene. Gel shift experiments revealed that GCF2 competes with these factors for interaction with the PDGF-A promoter. Overexpression of GCF2 suppressed endogenous PDGF-A expression in vascular endothelial cells and smooth muscle cells. GCF2 was induced on mechanical injury of cells in culture as well as after balloon injury of the rat carotid artery wall. Time course studies revealed the sustained induction of GCF2 after injury while PDGF-A levels sharply returned to baseline. Smooth muscle cell proliferation was inhibited by GCF2, an effect reversed by the addition of exogenous PDGF-AA. These findings demonstrate negative regulation of PDGF-A expression by GCF2. This is the first report of the induction of an endogenous transcriptional repressor in the rat vessel wall.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364563     DOI: 10.1161/01.res.84.11.1258

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  20 in total

1.  NAB2: a transcriptional brake for activated gene expression in the vessel wall?

Authors:  J M Miano; B C Berk
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

Review 2.  Catalytic DNAs as potential therapeutic agents and sequence-specific molecular tools to dissect biological function.

Authors:  L M Khachigian
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

3.  An upstream repressor element plays a role in Igf2 imprinting.

Authors:  S Eden; M Constancia; T Hashimshony; W Dean; B Goldstein; A C Johnson; I Keshet; W Reik; H Cedar
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

4.  Noncoding RNAs and LRRFIP1 regulate TNF expression.

Authors:  Lihua Shi; Li Song; Michael Fitzgerald; Kelly Maurer; Asen Bagashev; Kathleen E Sullivan
Journal:  J Immunol       Date:  2014-02-24       Impact factor: 5.422

5.  A Novel Angiotensin II-Induced Long Noncoding RNA Giver Regulates Oxidative Stress, Inflammation, and Proliferation in Vascular Smooth Muscle Cells.

Authors:  Sadhan Das; Erli Zhang; Parijat Senapati; Vishnu Amaram; Marpadga A Reddy; Kenneth Stapleton; Amy Leung; Linda Lanting; Mei Wang; Zhuo Chen; Mitsuo Kato; Hyung Jung Oh; Qianyun Guo; Xinyue Zhang; Bin Zhang; Haitong Zhang; Qinghao Zhao; Wei Wang; Yongjian Wu; Rama Natarajan
Journal:  Circ Res       Date:  2018-12-07       Impact factor: 17.367

6.  NF1/X represses PDGF A-chain transcription by interacting with Sp1 and antagonizing Sp1 occupancy of the promoter.

Authors:  Louise A Rafty; Fernando S Santiago; Levon M Khachigian
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

7.  Myeloid Leukemia Factor Acts in a Chaperone Complex to Regulate Transcription Factor Stability and Gene Expression.

Authors:  Jamie O Dyer; Arnob Dutta; Madelaine Gogol; Vikki M Weake; George Dialynas; Xilan Wu; Christopher Seidel; Ying Zhang; Laurence Florens; Michael P Washburn; Susan M Abmayr; Jerry L Workman
Journal:  J Mol Biol       Date:  2016-10-27       Impact factor: 5.469

8.  Sp1 phosphorylation regulates inducible expression of platelet-derived growth factor B-chain gene via atypical protein kinase C-zeta.

Authors:  L A Rafty; L M Khachigian
Journal:  Nucleic Acids Res       Date:  2001-03-01       Impact factor: 16.971

9.  Transcription profiling in human platelets reveals LRRFIP1 as a novel protein regulating platelet function.

Authors:  Alison H Goodall; Philippa Burns; Isabelle Salles; Iain C Macaulay; Chris I Jones; Diego Ardissino; Bernard de Bono; Sarah L Bray; Hans Deckmyn; Frank Dudbridge; Desmond J Fitzgerald; Stephen F Garner; Arief Gusnanto; Kerstin Koch; Cordelia Langford; Marie N O'Connor; Catherine M Rice; Derek Stemple; Jonathan Stephens; Mieke D Trip; Jaap-Jan Zwaginga; Nilesh J Samani; Nicholas A Watkins; Patricia B Maguire; Willem H Ouwehand
Journal:  Blood       Date:  2010-09-10       Impact factor: 22.113

10.  PDGF-A promoter and enhancer elements provide efficient and selective antineoplastic gene therapy in multiple cancer types.

Authors:  A Mishra; A K Ormerod; M L Cibull; B T Spear; S D Kraner; D M Kaetzel
Journal:  Cancer Gene Ther       Date:  2008-11-07       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.